Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-002682

COO, GENERAL COUNSEL &CORP SEC gave up 1,835 shares (to pay taxes)

  • COO, GENERAL COUNSEL &CORP SEC acquired 6,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC 2021-05-25 Option exercise +6,250 33,430 D: show line 1 in the form
Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC 2021-05-25 Shares withheld for taxes −1,835 $1.39 $2,551 31,595 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC 2021-05-25 Option exercise · Restricted Stock Units −6,250 68,750 D: show line 3 in the form
Loading xslF345X03/form4-05262021_040501.xml…